NEW YORK (GenomeWeb News) — PerkinElmer today said revenue for the third quarter increased 7 percent while profits fell 7 percent.
 
Total receipts for the three months ended Sept. 30 increased to $387 million from $360 million year over year.
 
Revenue from its life and analytical sciences division grew to $284 million from $259 million year over year.
 
The company spent $24.8 million on research and development in the quarter, up $3 million from last year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.